Insider · CIK 0001722140

Ceesay Abraham

Reports to the SEC for 5 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001722140

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-07	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,147 sh	$30.66	−$35.2K	452,245
2026-10-06	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−3,375 sh	$32.03	−$108K	453,392
2026-09-23	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−43 sh	$41.05	−$1,765.15	456,767
2026-09-23	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−215 sh	$39.86	−$8,569.943	456,810
2026-09-23	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,952 sh	$39.05	−$76.2K	457,025
2026-09-08	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−7,141 sh	$45.55	−$325K	460,046
2026-09-08	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,069 sh	$46.01	−$49.2K	458,977
2026-08-25	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−18.9K sh	$49.57	−$938K	467,187
2026-08-11	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−3,664 sh	$46.90	−$172K	511,402
2026-08-11	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−5,794 sh	$48.62	−$282K	486,108
2026-08-11	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−19.5K sh	$48.04	−$937K	491,902
2026-08-10	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−14.2K sh	$45.97	−$651K	523,436
2026-08-10	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−8,370 sh	$46.75	−$391K	515,066
2026-07-27	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,203 sh	$42.11	−$92.8K	537,614
2026-07-27	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−7 sh	$42.73	−$299.145	537,607
2026-07-14	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,729 sh	$40.57	−$111K	539,817
2026-07-14	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−5,481 sh	$39.72	−$218K	542,546
2026-06-29	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−876 sh	$40.34	−$35.3K	548,027
2026-06-29	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−7,344 sh	$39.77	−$292K	548,903
2026-05-08	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.A Award	Director	AAward	+1,438 sh	$177.62	+$255K	2,384
2026-02-18	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,100 sh	$29.80	−$62.6K	20,729
2026-02-18	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−3,552 sh	$29.05	−$103K	558,528
2026-02-18	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,281 sh	$29.80	−$68K	556,247
2026-02-18	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,983 sh	$29.04	−$86.6K	22,829
2026-02-02	RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+428K sh	—	—	428,000
2026-01-20	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−5,833 sh	$26.12	−$152K	562,080
2026-01-20	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−5,083 sh	$26.11	−$133K	25,812
2025-12-17	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,421 sh	$30.04	−$72.7K	31,410
2025-12-17	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−515 sh	$31.04	−$16K	30,895
2025-12-17	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,147 sh	$28.84	−$61.9K	33,831
2025-12-17	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,441 sh	$28.84	−$70.4K	571,305
2025-12-17	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,792 sh	$30.04	−$83.9K	568,513
2025-12-17	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−600 sh	$31.04	−$18.6K	567,913
2025-11-17	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,777 sh	$24.92	−$69.2K	576,802
2025-11-17	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−3,056 sh	$25.43	−$77.7K	573,746
2025-11-17	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,841 sh	$25.44	−$72.3K	35,978
2025-11-17	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,242 sh	$24.91	−$55.8K	38,819
2025-10-15	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−4,328 sh	$25.75	−$111K	41,816
2025-10-15	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−4,647 sh	$25.72	−$120K	580,765
2025-10-15	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,186 sh	$26.14	−$31K	579,579
2025-10-15	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−755 sh	$26.17	−$19.8K	41,061
2025-09-17	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−34.9K sh	$26.30	−$918K	46,844
2025-09-17	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−39.4K sh	$26.30	−$1.04M	586,812
2025-09-17	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,400 sh	$26.87	−$37.6K	585,412
2025-09-17	RAPPRapport Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−700 sh	$27.04	−$18.9K	46,144
2025-09-04	PCRXPacira BioSciences, Inc.S Sale	Director	SSale	−2,354 sh	$27.19	−$64K	9,039
2025-06-11	PCRXPacira BioSciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.3K sh	—	—	11,279
2025-06-11	PCRXPacira BioSciences, Inc.A Award	Director	AAward	+6,163 sh	—	—	11,393
2025-06-02	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Options (Right to Buy)A Award	Director	AAward	+2,082 sh	$135.04	+$281K	2,082
2025-06-02	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.A Award	Director	AAward	+946 sh	$135.04	+$128K	946

Recent filings

Accepted (ET)
Oct 8 16:074
Ceesay Abraham0001193125-26-417919
SEC(opens sec.gov)
Sep 244
Ceesay Abraham0001193125-26-401017
SEC(opens sec.gov)
Sep 94
Ceesay Abraham0001193125-26-386436
SEC(opens sec.gov)
Aug 264
Ceesay Abraham0001193125-26-368285
SEC(opens sec.gov)
Aug 124
Ceesay Abraham0001193125-26-346995
SEC(opens sec.gov)
Jul 294
Ceesay Abraham0001193125-26-323637
SEC(opens sec.gov)
Jul 154
Ceesay Abraham0001193125-26-304786
SEC(opens sec.gov)
Jul 14
Ceesay Abraham0001193125-26-292519
SEC(opens sec.gov)
May 114
Ceesay Abraham0001100682-26-000062
SEC(opens sec.gov)

Companies

Address

RAPPORT THERAPEUTICS, INC. 99 HIGH STREET, SUITE 2100

BOSTON, MA, 02110